- Home
- FTAI vs TEVA Comparison
FTAI vs TEVA Comparison
Compare FTAI & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTAI
- TEVA
- Stock Information
- Founded
- FTAI 2011
- TEVA 1901
- Country
- FTAI United States
- TEVA Israel
- Employees
- FTAI N/A
- TEVA N/A
- Industry
- FTAI Misc Corporate Leasing Services
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- FTAI Industrials
- TEVA Health Care
- Exchange
- FTAI Nasdaq
- TEVA Nasdaq
- Market Cap
- FTAI 17.9B
- TEVA 19.2B
- IPO Year
- FTAI 2015
- TEVA N/A
- Fundamental
- Price
- FTAI $128.46
- TEVA $20.93
- Analyst Decision
- FTAI Strong Buy
- TEVA Strong Buy
- Analyst Count
- FTAI 12
- TEVA 8
- Target Price
- FTAI $161.82
- TEVA $19.63
- AVG Volume (30 Days)
- FTAI 1.2M
- TEVA 9.9M
- Earning Date
- FTAI 10-30-2024
- TEVA 01-29-2025
- Dividend Yield
- FTAI 0.93%
- TEVA N/A
- EPS Growth
- FTAI N/A
- TEVA N/A
- EPS
- FTAI N/A
- TEVA N/A
- Revenue
- FTAI $1,548,819,000.00
- TEVA $16,772,000,000.00
- Revenue This Year
- FTAI $49.89
- TEVA $4.70
- Revenue Next Year
- FTAI $21.71
- TEVA $4.47
- P/E Ratio
- FTAI N/A
- TEVA N/A
- Revenue Growth
- FTAI 36.77
- TEVA 9.81
- 52 Week Low
- FTAI $44.49
- TEVA $10.13
- 52 Week High
- FTAI $177.18
- TEVA $21.05
- Technical
- Relative Strength Index (RSI)
- FTAI 29.90
- TEVA 74.43
- Support Level
- FTAI $124.28
- TEVA $16.25
- Resistance Level
- FTAI $168.72
- TEVA $17.72
- Average True Range (ATR)
- FTAI 6.50
- TEVA 0.72
- MACD
- FTAI -4.29
- TEVA 0.38
- Stochastic Oscillator
- FTAI 14.11
- TEVA 97.64
About FTAI FTAI Aviation Ltd.
FTAI Aviation Ltd is a aerospace company .It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate strong and stable cash flows with the potential for earnings growth and asset appreciation.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.